Business Pharmaceutical Companies Continue to Withhold Drug Pricing Transparency The Trump administration’s proposed rule leaves pharmaceutical companies and pharmacy benefit managers (PBMs) without a requirement to disclose the actual prices paid for prescription... Editorial23 December, 2025